Home LiteratureArticle Details
PMID: 1996098 Published · ppublish English Journal Article Research Support, U.S. Gov't, P.H.S.

Episome-generated N-myc antisense RNA restricts the differentiation potential of primitive neuroectodermal cell lines.

Molecular and cellular biology ·Vol. 11 ·No. 3 ·1991-03-00 ·Pages 1360-71

Whitesell L, Rosolen A, Neckers LM

Abstract

Neuroectodermal tumors of childhood provide a unique opportunity to examine the role of genes potentially regulating neuronal growth and differentiation because many cell lines derived from these tumors are composed of at least two distinct morphologic cell types. These types display variant phenotypic characteristics and spontaneously interconvert, or transdifferentiate, in vitro. The factors that regulate transdifferentiation are unknown. Application of antisense approaches to the transdifferentiation process has allowed us to explore the precise role that N-myc may play in regulating developing systems. We now report construction of an episomally replicating expression vector designed to generate RNA antisense to part of the human N-myc gene. Such a vector is able to specifically inhibit N-myc expression in cell lines carrying both normal and amplified N-myc alleles. Inhibition of N-myc expression blocks transdifferentiation in these lines, with accumulation of cells of an intermediate phenotype. A concomitant decrease in growth rate but not loss of tumorigenicity was observed in the N-myc nonamplified cell line CHP-100. Vector-generated antisense RNA should allow identification of genes specifically regulated by the proto-oncogene N-myc.

MeSH Terms
Animals Biomarkers Blotting, Western Cell Differentiation Cloning, Molecular Cricetinae DNA/biosynthesis Epithelium/physiology Flow Cytometry Gene Expression Genetic Vectors Humans In Vitro Techniques Mice Neoplasms, Experimental/pathology Nervous System/cytology Plasmids Proto-Oncogene Mas Proto-Oncogene Proteins c-myc/genetics RNA, Antisense Transfection
Chemicals
Biomarkers MAS1 protein, human Proto-Oncogene Mas Proto-Oncogene Proteins c-myc RNA, Antisense DNA
Authors & Affiliations
3 authors, click to expand affiliations / ORCID
Whitesell L
Tumor Cell Biology Section, National Cancer Institute, Bethesda, Maryland 20892.
Rosolen A
Neckers L M
References (31)
31 references, click to expand
  1. Definition of a continuous human cell line derived from neuroblastoma.
    Cancer Res. 1970 Aug;30(8):2110-8 PMID: 5459762
  2. Antisense inhibition of single copy N-myc expression results in decreased cell growth without reduction of c-myc protein in a neuroepithelioma cell line.
    Cancer Res. 1990 Oct 1;50(19):6316-22 PMID: 2205380
  3. Amplified DNA with limited homology to myc cellular oncogene is shared by human neuroblastoma cell lines and a neuroblastoma tumour.
    Nature. 1983 Sep 15-21;305(5931):245-8 PMID: 6888561
  4. Coordinate morphological and biochemical interconversion of human neuroblastoma cells.
    J Natl Cancer Inst. 1983 Oct;71(4):741-7 PMID: 6137586
  5. Transposition and amplification of oncogene-related sequences in human neuroblastomas.
    Cell. 1983 Dec;35(2 Pt 1):359-67 PMID: 6197179
  6. Retinoic acid induces neuronal differentiation of a cloned human embryonal carcinoma cell line in vitro.
    Dev Biol. 1984 Jun;103(2):285-93 PMID: 6144603
  7. Expression and amplification of the N-myc gene in primary retinoblastoma.
    Nature. 1984 May 31-Jun 6;309(5967):458-60 PMID: 6728001
  8. Decreased expression of N-myc precedes retinoic acid-induced morphological differentiation of human neuroblastoma.
    Nature. 1985 Jan 31-Feb 6;313(6001):404-6 PMID: 3855502
  9. Stable replication of plasmids derived from Epstein-Barr virus in various mammalian cells.
    Nature. 1985 Feb 28-Mar 6;313(6005):812-5 PMID: 2983224
  10. N-myc can cooperate with ras to transform normal cells in culture.
    Proc Natl Acad Sci U S A. 1985 Aug;82(16):5455-9 PMID: 3860871
  11. Association of multiple copies of the N-myc oncogene with rapid progression of neuroblastomas.
    N Engl J Med. 1985 Oct 31;313(18):1111-6 PMID: 4047115
  12. Differential expression of myc family genes during murine development.
    Nature. 1986 Feb 27-Mar 5;319(6056):780-3 PMID: 2419762
  13. Human small-cell lung cancers show amplification and expression of the N-myc gene.
    Proc Natl Acad Sci U S A. 1986 Feb;83(4):1092-6 PMID: 2869482
  14. Inducible production of c-fos antisense RNA inhibits 3T3 cell proliferation.
    Proc Natl Acad Sci U S A. 1986 Jul;83(13):4794-8 PMID: 3523478
  15. Increased N-myc expression following progressive growth of human neuroblastoma.
    Cancer Res. 1986 Aug;46(8):4139-42 PMID: 3731081
  16. Identification and characterization of the NMYC gene product in human neuroblastoma cells by monoclonal antibodies with defined specificities.
    Proc Natl Acad Sci U S A. 1986 Aug;83(16):5929-33 PMID: 2426708
  17. Coordinate changes in neuronal phenotype and surface antigen expression in human neuroblastoma cell variants.
    Cancer Res. 1987 Mar 1;47(5):1383-9 PMID: 3028608
  18. Use of an Epstein-Barr virus episomal replicon for anti-sense RNA-mediated gene inhibition in a human cytotoxic T-cell clone.
    Proc Natl Acad Sci U S A. 1988 Jun;85(11):4010-4 PMID: 2453884
  19. Modulation of N-myc expression, but not tumorigenicity, accompanies phenotypic conversion of neuroblastoma cells in prolonged culture.
    Prog Clin Biol Res. 1988;271:103-20 PMID: 2457220
  20. Differential expression of intermediate filaments and fibronectin in human neuroblastoma cells.
    Prog Clin Biol Res. 1988;271:277-89 PMID: 2900512
  21. N-myc proto-oncogene expression during organogenesis in the developing mouse as revealed by in situ hybridization.
    J Cell Biol. 1988 Oct;107(4):1325-35 PMID: 3049618
  22. Phenotypic diversification in human neuroblastoma cells: expression of distinct neural crest lineages.
    Cancer Res. 1989 Jan 1;49(1):219-25 PMID: 2535691
  23. Differential regulation of N-myc and c-myc expression in F9 teratocarcinoma cells.
    Oncogene Res. 1988;3(3):287-92 PMID: 3060804
  24. Construction of an EBNA-producing line of well-differentiated human hepatoma cells and of appropriate Epstein-Barr virus-based shuttle vectors.
    Gene. 1989 Mar 15;76(1):27-39 PMID: 2545532
  25. Inactivation of the N-myc gene product by single amino acid substitution of leucine residues located in the leucine-zipper region.
    Oncogene. 1989 Aug;4(8):999-1002 PMID: 2668849
  26. Directional antisense and sense cDNA cloning using Epstein-Barr virus episomal expression vectors.
    Gene. 1989 Sep 30;81(2):285-94 PMID: 2478421
  27. Rapid and transient decrease of N-myc expression in retinoic acid-induced differentiation of OTF9 teratocarcinoma stem cells.
    Mol Cell Biol. 1990 Feb;10(2):486-91 PMID: 2405249
  28. High-frequency disruption of the N-myc gene in embryonic stem and pre-B cell lines by homologous recombination.
    Mol Cell Biol. 1990 Apr;10(4):1799-804 PMID: 2181287
  29. N-myc down regulates neural cell adhesion molecule expression in rat neuroblastoma.
    Mol Cell Biol. 1990 May;10(5):2012-6 PMID: 2183016
  30. Are myc proteins transcription factors?
    Cancer Cells. 1990 Mar;2(3):69-75 PMID: 2202379
  31. Establishment and characterization of human neuroblastoma cell lines.
    Cancer Res. 1976 Sep;36(9 pt.1):3094-100 PMID: 10079
Article Info
Journal
Molecular and cellular biology
Abbr.
Mol Cell Biol
ISSN
0270-7306
Published
1991-03-00
Pages
1360-71
Language
English
Region
United States
NLM ID
8109087
PMCID
PMC369407
Subset
IM
Grants
NICHD NIH HHS · N01-HD-6-2915 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com